1. Home
  2. GNTA vs STCN Comparison

GNTA vs STCN Comparison

Compare GNTA & STCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTA
  • STCN
  • Stock Information
  • Founded
  • GNTA 2014
  • STCN 1986
  • Country
  • GNTA Italy
  • STCN United States
  • Employees
  • GNTA N/A
  • STCN N/A
  • Industry
  • GNTA Biotechnology: Biological Products (No Diagnostic Substances)
  • STCN Advertising
  • Sector
  • GNTA Health Care
  • STCN Consumer Discretionary
  • Exchange
  • GNTA Nasdaq
  • STCN Nasdaq
  • Market Cap
  • GNTA 67.4M
  • STCN 63.4M
  • IPO Year
  • GNTA 2021
  • STCN 1994
  • Fundamental
  • Price
  • GNTA $5.34
  • STCN $10.40
  • Analyst Decision
  • GNTA Strong Buy
  • STCN
  • Analyst Count
  • GNTA 1
  • STCN 0
  • Target Price
  • GNTA $25.00
  • STCN N/A
  • AVG Volume (30 Days)
  • GNTA 28.4K
  • STCN 11.9K
  • Earning Date
  • GNTA 01-01-0001
  • STCN 12-12-2024
  • Dividend Yield
  • GNTA N/A
  • STCN N/A
  • EPS Growth
  • GNTA N/A
  • STCN 203.29
  • EPS
  • GNTA N/A
  • STCN 3.17
  • Revenue
  • GNTA N/A
  • STCN $169,044,000.00
  • Revenue This Year
  • GNTA N/A
  • STCN N/A
  • Revenue Next Year
  • GNTA N/A
  • STCN N/A
  • P/E Ratio
  • GNTA N/A
  • STCN $3.19
  • Revenue Growth
  • GNTA N/A
  • STCN N/A
  • 52 Week Low
  • GNTA $2.20
  • STCN $7.36
  • 52 Week High
  • GNTA $7.28
  • STCN $13.00
  • Technical
  • Relative Strength Index (RSI)
  • GNTA 56.89
  • STCN 57.19
  • Support Level
  • GNTA $4.89
  • STCN $9.90
  • Resistance Level
  • GNTA $6.20
  • STCN $10.29
  • Average True Range (ATR)
  • GNTA 0.70
  • STCN 0.39
  • MACD
  • GNTA -0.06
  • STCN 0.11
  • Stochastic Oscillator
  • GNTA 37.32
  • STCN 100.00

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

About STCN Steel Connect Inc.

Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.

Share on Social Networks: